HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 191 filers reported holding HERON THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $296,000 | -39.7% | 51,695 | -3.9% | 0.01% | -53.3% |
Q4 2021 | $491,000 | +20.3% | 53,804 | +41.0% | 0.03% | -6.2% |
Q3 2021 | $408,000 | +8.5% | 38,154 | +57.5% | 0.03% | 0.0% |
Q2 2021 | $376,000 | -18.3% | 24,229 | -14.7% | 0.03% | -23.8% |
Q1 2021 | $460,000 | -57.2% | 28,393 | -60.8% | 0.04% | -39.1% |
Q3 2020 | $1,074,000 | +160.0% | 72,449 | +158.0% | 0.07% | +137.9% |
Q2 2020 | $413,000 | -55.8% | 28,085 | -64.7% | 0.03% | -57.4% |
Q1 2020 | $935,000 | -16.5% | 79,631 | +67.1% | 0.07% | +3.0% |
Q4 2019 | $1,120,000 | -35.1% | 47,651 | -32.5% | 0.07% | -46.3% |
Q1 2019 | $1,726,000 | +154.6% | 70,639 | +230.0% | 0.12% | +141.2% |
Q3 2018 | $678,000 | -31.4% | 21,408 | -15.9% | 0.05% | -26.1% |
Q2 2018 | $989,000 | +5.2% | 25,456 | -51.0% | 0.07% | -33.0% |
Q4 2017 | $940,000 | +356.3% | 51,907 | +306.3% | 0.10% | +98.1% |
Q3 2017 | $206,000 | -41.6% | 12,776 | -52.5% | 0.05% | -7.1% |
Q4 2016 | $353,000 | +19.3% | 26,915 | +143.1% | 0.06% | +115.4% |
Q4 2015 | $296,000 | – | 11,072 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG KEVIN C | 760 | $1,900 | 100.00% |
Velan Capital Investment Management LP | 2,500,000 | $6,250,000 | 5.52% |
GREAT POINT PARTNERS LLC | 6,360,161 | $15,900,403 | 3.12% |
Cheyne Capital Management (UK) LLP | 318,008 | $795,020 | 1.39% |
TANG CAPITAL MANAGEMENT LLC | 3,755,934 | $9,389,835 | 1.36% |
Rubric Capital Management LP | 11,750,000 | $29,375,000 | 1.28% |
Orchard Capital Management, LLC | 1,391,080 | $3,477,700 | 1.17% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 267,028 | $667,570 | 0.81% |
CM Management, LLC | 250,000 | $625 | 0.75% |
Tejara Capital Ltd | 493,619 | $1,234,048 | 0.71% |